Differences

This shows you the differences between two versions of the page.

--- home:translations:german [03.12.2019] – [Beenden des Protokolls] sallieq
+++ home:translations:german [05.10.2019] – [Data] sallieq
@@ Line 285: / Line 285: @@
  related articlege [[home:mp:break|Eine Pause vom Marshall Protocol]]
-==== Data ====
-[[home:patients:cohort_statistics#later_information_2013|Success rates for various Dx, compiled in 2013]]
@@ Line 303: / Line 301: @@
 PatientInnen, die die Einnahme von Olmesartan beenden, unterbrechen ihre weitere Genesung.
+===== Data =====
+[[home:patients:cohort_statistics#later_information_2013|Success rates for various Dx, compiled in 2013]]
+[[home:food:aim_health:aging|Olmesartan research]]
+==== Response in 5 diagnoses ====
+ TOTALS: 864 members;573 report success; 119 report no success; and for 172 results are not clear.
+SUCCESS RATES: Over all success rate 66.32% Over all unsuccessful 13.77% Over all unsure 19.91%
+Sarcoidosis success 75.8%
+Chronic Fatigue Syndrome success 60.1%
+Lyme disease success 66.9%
+Rheumatoid arthritis success 69.2%
+Fibromyalgia success 64.2%
+All Other Th1 disease success 59.8%
 ===== Notes and comments =====

home/translations/german.txt · Last modified: 09.14.2022 by 127.0.0.1